Skip to content
GLP-1 Desk
Menu

Head-to-head dispatch

Get Thin MD vs Medro

Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.

Dispatch #39Desk pick
Get Thin MD

Get Thin MD is a nationwide async telehealth platform offering compounded semaglutide and tirzepatide injections plus brand-name Ozempic and Zepbound where appropriate, alongside a broader wellness menu…

Marked down on: Compounded medications aren't FDA-approved and lack the review of brand-name GLP-1s

vs
Dispatch #130
Medro

Medro (Medro Health Technologies, Inc.) is a telehealth brand whose GLP-1 program offers compounded semaglutide and tirzepatide, plus brand-name GLP-1s when eligible, via a partner medical group and…

Marked down on: Does not name its compounding pharmacy or its clinical partner medical group, so the fulfillment chain is not verifiable.

Get Thin MD takes this head-to-head with the higher Desk Score, 82/100 (B−) against 71/100 (C) for Medro. Medro still holds its ground where its strengths line up with yours.

Desk Score, dimension by dimension

Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.

Get Thin MD

82/100

B−

Overall

Medro

71/100

C

Price transparency

76
52

State access

86
86

Molecule range

79
79

Onboarding speed

88
78

Support responsiveness

90
64

Licensing & trust

73
70

The spec sheet

FieldGet Thin MDMedro
Semaglutide$199/mo (compounded)$199/mo (compounded)
Tirzepatide$299/mo (compounded)$299/mo (compounded)
CoverageAll 50 statesAll 50 states
Brand-nameYesYes
Oral optionInjectable onlyInjectable only
Best forReaders who want lowest-priced compounded semaglutide on a 3-month commitment, with brand-name Ozempic/Zepbound also available.Readers who want compounded or brand semaglutide/tirzepatide with transparent tiered pricing and no membership, all 50 states.
Desk Score82/100B−71/100C

The verdict

Desk pick — Get Thin MD

Get Thin MD takes this head-to-head with the higher Desk Score, 82/100 (B−) against 71/100 (C) for Medro. Medro still holds its ground where its strengths line up with yours.

Choose Get Thin MD if…

Readers who want lowest-priced compounded semaglutide on a 3-month commitment, with brand-name Ozempic/Zepbound also available.

$199/mo (compounded) sema · $299/mo (compounded) tirz · All 50 states

Choose Medro if…

Readers who want compounded or brand semaglutide/tirzepatide with transparent tiered pricing and no membership, all 50 states.

$199/mo (compounded) sema · $299/mo (compounded) tirz · All 50 states

Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Get Thin MD · Medro.

Also here

CoreAge Rx tops every dispatch at 94/100

Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.

More head-to-heads

Or see the full comparison hub and the complete ranking.

Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.